The proposed bill, known as the Enhanced Oversight and Accountability for the Prescription of Psychotropic Drug Act, aims to improve the monitoring and safety of psychotropic drug prescriptions for children receiving medical assistance. It mandates that prescribers provide parents with FDA medication guides detailing potential side effects and risks associated with these drugs, particularly for off-label use in children aged 0-5. Written informed consent from parents is required before any psychotropic medication can be prescribed, ensuring that they are fully aware of the associated risks.

Additionally, the bill establishes a secure online reporting system for adverse drug reactions related to psychotropic medications prescribed to children. This system will allow parents and caregivers to report any harmful reactions, which will be compiled into quarterly reports by the Secretary of Health and Environment. These reports will be submitted to various legislative committees to facilitate oversight and improve the safety of prescribing practices. The bill emphasizes the importance of informed consent and aims to enhance accountability in the prescription of psychotropic drugs to vulnerable pediatric populations.